[ Price : $8.95]
Elevar Therapeutics files an NDA for lirafugratinib as a second-line treatment for patients with cholangiocarcinoma whose tumors h...[ Price : $8.95]
Sen. Rick Scott (R-FL) introduces legislation that would require prescription drug labels in the U.S. to disclose where drugs and ...[ Price : $8.95]
FDA discontinues the use of its Quality System Inspection Technique for medical device inspections and will instead conduct inspec...[ Price : $8.95]
Grail files the final module of its PMA for the companys multi-cancer early detection blood test.[ Price : $8.95]
FDA awards Biogen a breakthrough therapy designation for its experimental antibody litifilimab for treating cutaneous lupus erythe...[ Price : $8.95]
A group of Democratic senators ask HHS Office of Inspector General to clarify how it will oversee direct-to-consumer prescription ...[ Price : $8.95]
University of Southern California public policy professor Genevieve Kanter airs concerns about the impact of the many changes that...[ Price : $8.95]
FDA approves Tenpoint Therapeutics Yuvezzi as the only combination eye drop approved to treat presbyopia in adults.